Noscapine Hydrochloride Marel (Noscapine Hydrochloride)

Noscapine Hydrochloride is an antitussive that acts on the central cough reflex.

• Acute cough: provides symptomatic relief of sudden‑onset, non‑productive cough.
• Chronic cough: helps manage persistent cough when other causes have been excluded.
• Cough due to upper respiratory tract infection: alleviates irritation‑driven coughing associated with common colds or viral infections.

• Noscapine Hydrochloride exerts its antitussive effect primarily through central inhibition of the cough reflex, likely involving antagonism of sigma‑1 receptors in the brainstem. This modulation reduces the neuronal firing that triggers cough, without producing the opioid‑related respiratory depression seen with some other cough suppressants.

Adverse reactions to noscapine are generally mild, but patients should be aware of both common and serious possibilities.

Common Side Effects

• Nausea: mild stomach upset that may resolve with continued use.
• Dizziness: transient light‑headedness, especially after the first doses.
• Drowsiness: occasional sleepiness, advise caution when driving.
• Headache: mild to moderate headache reported by some users.
• Gastro‑intestinal discomfort: abdominal cramping or mild diarrhea.
• Mild skin rash: transient erythema or itching.

Serious or Rare Side Effects

• Allergic reactions: including urticaria, angioedema, or anaphylaxis.
• Severe skin reactions: such as Stevens‑Johnson syndrome.
• Hepatic dysfunction: elevated liver enzymes or jaundice.
• Hematologic effects: rare neutropenia or thrombocytopenia.
• Seizures: isolated reports of convulsive episodes.
• Respiratory depression: extremely rare, usually with overdose or concomitant CNS depressants.

Before initiating therapy, clinicians should consider several safety aspects.

• Pregnancy: safety not established; use only if potential benefit outweighs risk.
• Breastfeeding: unknown excretion in milk; caution advised.
• Renal impairment: dose adjustment may be needed; monitor renal function.
• Hepatic impairment: use with caution; monitor liver enzymes.
• Concomitant medications: review for potential interactions, especially CNS depressants.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Noscapine may interact with other medicines, requiring attention to the level of risk.

Major Interactions (Avoid)

• CNS depressants: may enhance sedation or drowsiness.
• Other antitussives: risk of excessive cough suppression and respiratory depression.

Moderate Interactions (Monitor Closely)

• Antihistamines: may increase drowsiness.
• Opioid analgesics: additive risk of respiratory depression.
• Alcohol: can potentiate dizziness and sedation.
• Certain antidepressants (e.g., MAO inhibitors): may alter central nervous system effects.